160 related articles for article (PubMed ID: 24283589)
1. Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI.
Verdoia M; Secco GG; Barbieri L; Cassetti E; Schaffer A; Sinigaglia F; Marino P; Suryapranata H; De Luca G;
Platelets; 2014; 25(5):367-72. PubMed ID: 24283589
[TBL] [Abstract][Full Text] [Related]
2. Platelet PIA1/PIA2 polymorphism and the risk of periprocedural myocardial infarction in patients with acute coronary syndromes undergoing coronary angioplasty.
Verdoia M; Secco GG; Cassetti E; Schaffer A; Barbieri L; Perrone-Filardi P; Marino P; Suryapranata H; Sinigaglia F; De Luca G
Blood Coagul Fibrinolysis; 2014 Mar; 25(2):107-13. PubMed ID: 24480844
[TBL] [Abstract][Full Text] [Related]
3. Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty.
Verdoia M; Camaro C; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G
Atherosclerosis; 2013 May; 228(1):136-41. PubMed ID: 23518179
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine and risk of periprocedural myocardial infarction in patients undergoing coronary stenting.
Verdoia M; Schaffer A; Barbieri L; Cassetti E; Di Giovine G; Marino P; De Luca G;
J Cardiovasc Med (Hagerstown); 2015 Feb; 16(2):100-5. PubMed ID: 24625566
[TBL] [Abstract][Full Text] [Related]
5. Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban.
Verdoia M; Pergolini P; Barbieri L; Rolla R; Nardin M; Negro F; Suryapranata H; De Luca G;
Thromb Res; 2018 Apr; 164():17-23. PubMed ID: 29475177
[TBL] [Abstract][Full Text] [Related]
6. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
Mangiacapra F; Barbato E; Patti G; Gatto L; Vizzi V; Ricottini E; D'Ambrosio A; Wijns W; Di Sciascio G
JACC Cardiovasc Interv; 2010 Mar; 3(3):318-23. PubMed ID: 20298992
[TBL] [Abstract][Full Text] [Related]
7. Effect of diabetes mellitus on periprocedural myocardial infarction in patients undergoing coronary stent implantation.
Verdoia M; Barbieri L; Schaffer A; Cassetti E; Di Giovine G; Nardin M; Bellomo G; Marino P; De Luca G;
Diabetes Metab Res Rev; 2015 Jan; 31(1):85-92. PubMed ID: 24898423
[TBL] [Abstract][Full Text] [Related]
8. Impact of the Polymorphism rs5751876 of the Purinergic Receptor ADORA2A on Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention.
Negro F; Verdoia M; Nardin M; Suryapranata H; Kedhi E; Dudek D; De Luca G;
J Atheroscler Thromb; 2021 Feb; 28(2):137-145. PubMed ID: 33342966
[TBL] [Abstract][Full Text] [Related]
9. Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
Verdoia M; Barbieri L; Schaffer A; Cassetti E; Di Giovine G; Bellomo G; Marino P; Sinigaglia F; De Luca G
J Thromb Thrombolysis; 2014 Apr; 37(3):345-52. PubMed ID: 23793523
[TBL] [Abstract][Full Text] [Related]
10. MTHFR polymorphism and risk of periprocedural myocardial infarction after coronary stenting.
Verdoia M; Schaffer A; Cassetti E; Barbieri L; Di Giovine G; Marino P; De Luca G;
Nutr Metab Cardiovasc Dis; 2014 May; 24(5):532-7. PubMed ID: 24418373
[TBL] [Abstract][Full Text] [Related]
11. Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients.
Verdoia M; Schaffer A; Barbieri L; Di Giovine G; Marino P; Suryapranata H; De Luca G;
J Diabetes Complications; 2015; 29(4):517-22. PubMed ID: 25736187
[TBL] [Abstract][Full Text] [Related]
12. Effect of estimated glomerular filtration rate on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention.
Vatankulu MA; Murat SN; Demircelik B; Turfan M; Sonmez O; Duran M; Bacaksiz A; Ornek E; Tasal A; Goktekin O
Ren Fail; 2013 Aug; 35(7):931-5. PubMed ID: 23803143
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
Lindsey JB; Marso SP; Pencina M; Stolker JM; Kennedy KF; Rihal C; Barsness G; Piana RN; Goldberg SL; Cutlip DE; Kleiman NS; Cohen DJ;
JACC Cardiovasc Interv; 2009 Nov; 2(11):1074-82. PubMed ID: 19926047
[TBL] [Abstract][Full Text] [Related]
14. Comparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary intervention.
Mangiacapra F; Patti G; Peace A; Gatto L; Vizzi V; Ricottini E; D'Ambrosio A; Muller O; Barbato E; Di Sciascio G
Am J Cardiol; 2010 Sep; 106(5):619-23. PubMed ID: 20723634
[TBL] [Abstract][Full Text] [Related]
15. Platelet-larger cell ratio and the risk of periprocedural myocardial infarction after percutaneous coronary revascularization.
Verdoia M; Barbieri L; Schaffer A; Cassetti E; Marino P; Bellomo G; Sinigaglia F; De Luca G;
Heart Vessels; 2015 Jan; 30(1):20-7. PubMed ID: 24297745
[TBL] [Abstract][Full Text] [Related]
16. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
[TBL] [Abstract][Full Text] [Related]
17. Correlation of platelet reactivity and C-reactive protein levels to occurrence of peri-procedural myocardial infarction in patients undergoing percutaneous coronary intervention (from the ARMYDA-CRP study).
Patti G; Mangiacapra F; Ricottini E; Cannatà A; Cavallari I; Vizzi V; D'Ambrosio A; Dicuonzo G; Di Sciascio G
Am J Cardiol; 2013 Jun; 111(12):1739-44. PubMed ID: 23538022
[TBL] [Abstract][Full Text] [Related]
18. Relationship of non-cardiac biomarkers with periprocedural myocardial injury in patients undergoing percutaneous coronary intervention.
Zeng RX; Li JJ; Liao PD; Zhang MZ
Int J Cardiol; 2016 Oct; 221():726-33. PubMed ID: 27428312
[TBL] [Abstract][Full Text] [Related]
19. Elevated plasma fibrinogen rather than residual platelet reactivity after clopidogrel pre-treatment is associated with an increased ischemic risk during elective percutaneous coronary intervention.
Ang L; Thani KB; Ilapakurti M; Lee MS; Palakodeti V; Mahmud E
J Am Coll Cardiol; 2013 Jan; 61(1):23-34. PubMed ID: 23287370
[TBL] [Abstract][Full Text] [Related]
20. Association between changes in platelet reactivity during elective percutaneous coronary intervention and periprocedural myocardial infarction: A pilot study.
Kawai Y; Miyoshi T; Nakamura K; Shokoku G; Yamamoto K; Ono T; Tokioka K; Ohe T; Ito H
J Cardiol; 2019 Feb; 73(2):134-141. PubMed ID: 30201315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
